1. Construction of a pneumolysin deficient mutant in streptococcus pneumoniae serotype 1 strain 519/43 and phenotypic characterisation.
- Author
-
Terra, Vanessa S., Plumptre, Charles D., Wall, Emma C., Brown, Jeremy S., and Wren, Brendan W.
- Subjects
- *
STREPTOCOCCUS pneumoniae , *ERYTHROCYTES , *MIDDLE-income countries , *PROOF of concept , *COMMUNICABLE diseases - Abstract
Streptococcus pneumoniae capsular serotype 1 continues to pose a huge infectious disease burden in low- and middle-income countries, particularly in West Africa. However, studies on this important serotype have been hampered by the inability to genetically modify these strains. In this study we have genetically modified a serotype 1 strain (519/43), the first time that this has been achieved for this serotype, providing the methodology for a deeper understanding of its biology and pathogenicity. As proof of principle we constructed a defined pneumolysin mutant and showed that it lost its ability to lyse red blood cells. We also showed that when mice were infected intranasally with the mutant 519/43Δ ply there was no significant difference between the load of bacteria in lungs and blood when compared to the wild type 519/43. When mice were infected intraperitoneally there were significantly fewer bacteria recovered from blood for the mutant 519/43Δ ply strain, although all mice still displayed signs of disease. Our study demonstrates S. pneumoniae serotype 1 strains can be genetically manipulated using our methodology and demonstrate that the ability to cause pneumonia in mice is independent of active pneumolysin for the 519/43 serotype 1 strain. • Mutagenesis in Serotype 1 S. pneumoniae is possible in strain 519/43. • 519/43 possess pneumolysin D380 N, however it is not more haemolytic than the pneumolysin present in D39. • 519/43 strain is capable of causing disease independently of pneumolysin. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF